How Analysts Rate Accenture Post Q4 Results?

Analysts mostly lauded Accenture PLC's ACN Q4 results and FY22 outlook, slightly cautioned by the Q4 revenue miss.
Related Content: Accenture Clocks 24% Revenue Growth In Q4, Hikes Dividend, Adds $3B Share Buyback
Piper Sandler analyst Arvind Ramnani bumped the PT to $354 from $302, suggesting a 3.2% upside, and kept a Neutral rating.
Citi analyst Ashwin Shirvaikar raised the PT to $390 from $340, implying a 13.7% upside, and reiterated a Buy.
Morgan Stanley analyst James Faucette lifted the PT to $400 from $380, indicating a 16.6% upside, and maintained an Overweight.
Argus analyst Jim Kelleher raised the PT to $400 from $330 and affirmed a Buy.
Price Action: ACN shares traded lower by 0.23% at $342.32 on the last check Friday.

Momentum35.95

Growth51.05

Quality15.03

Value11.51

Short

Medium

Long

Analyst Calendar